» Articles » PMID: 22213072

UMD-DYSF, a Novel Locus Specific Database for the Compilation and Interactive Analysis of Mutations in the Dysferlin Gene

Overview
Journal Hum Mutat
Specialty Genetics
Date 2012 Jan 4
PMID 22213072
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the dysferlin gene (DYSF) lead to a complete or partial absence of the dysferlin protein in skeletal muscles and are at the origin of dysferlinopathies, a heterogeneous group of rare autosomal recessive inherited neuromuscular disorders. As a step towards a better understanding of the DYSF mutational spectrum, and towards possible inclusion of patients in future therapeutic clinical trials, we set up the Universal Mutation Database for Dysferlin (UMD-DYSF), a Locus-Specific Database developed with the UMD® software. The main objective of UMD-DYSF is to provide an updated compilation of mutational data and relevant interactive tools for the analysis of DYSF sequence variants, for diagnostic and research purposes. In particular, specific algorithms can facilitate the interpretation of newly identified intronic, missense- or isosemantic-exonic sequence variants, a problem encountered recurrently during genetic diagnosis in dysferlinopathies. UMD-DYSF v1.0 is freely accessible at www.umd.be/DYSF/. It contains a total of 742 mutational entries corresponding to 266 different disease-causing mutations identified in 558 patients worldwide diagnosed with dysferlinopathy. This article presents for the first time a comprehensive analysis of the dysferlin mutational spectrum based on all compiled DYSF disease-causing mutations reported in the literature to date, and using the main bioinformatics tools offered in UMD-DYSF.

Citing Articles

Analysis of Exon Skipping Applicability for Dysferlinopathies.

Leckie J, Rodriguez S, Krahn M, Yokota T Cells. 2025; 14(3).

PMID: 39936969 PMC: 11817064. DOI: 10.3390/cells14030177.


Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.

Poudel B, Fletcher S, Wilton S, Aung-Htut M Int J Mol Sci. 2024; 25(11).

PMID: 38891760 PMC: 11171558. DOI: 10.3390/ijms25115572.


The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.

Anwar S, Yokota T Biomolecules. 2024; 14(3).

PMID: 38540676 PMC: 10968265. DOI: 10.3390/biom14030256.


Genetic screening of an endemic mutation in the DYSF gene in an isolated, mountainous population in the Republic of Dagestan.

Bardakov S, Deev R, Isaev A, Khromov-Borisov N, Kopylov E, Savchuk M Mol Genet Genomic Med. 2023; 11(10):e2236.

PMID: 37553796 PMC: 10568376. DOI: 10.1002/mgg3.2236.


An in-frame pseudoexon activation caused by a novel deep-intronic variant in the dysferlin gene.

Sun C, Xie Z, Cong L, Xu Y, Liu Z Ann Clin Transl Neurol. 2022; 10(2):292-296.

PMID: 36542547 PMC: 9930419. DOI: 10.1002/acn3.51716.